Your browser doesn't support javascript.
loading
The risk of hepatitis B virus reactivation and the role of antiviral prophylaxis in hepatitis B surface antigen negative/hepatitis B core antibody positive patients with diffuse large B-cell lymphoma receiving rituximab-based chemotherapy.
Lu, Shasha; Xu, Yu; Mu, Qitian; Cao, Lihong; Chen, Jian; Zhu, Zhijuan; Lou, Yinjun; Meng, Haitao; Qian, Wenbin; Tong, Hongyan; Mai, Wenyuan; Huang, Jian; Yu, Wenjuan; Zhao, Xiaoying; Jin, Jie.
Afiliação
  • Lu S; Department of Hematology, Institute of Hematology, the First Affiliated Hospital, Zhejiang University College of Medicine , Hangzhou, Zhejiang , China.
Leuk Lymphoma ; 56(4): 1027-32, 2015 Apr.
Article em En | MEDLINE | ID: mdl-25065698

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Antivirais / Ativação Viral / Protocolos de Quimioterapia Combinada Antineoplásica / Linfoma Difuso de Grandes Células B Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2015 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Antivirais / Ativação Viral / Protocolos de Quimioterapia Combinada Antineoplásica / Linfoma Difuso de Grandes Células B Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2015 Tipo de documento: Article